A Multicenter Phase II Study of Second‐Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy
The Oncologist, EarlyView.
Prognosis and Management of BRAF V600E–Mutated Pregnancy‐Associated Melanoma
The Oncologist, EarlyView.
Clinical Characteristics of COVID‐19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records
The Oncologist, EarlyView.
An Open‐Label Study of the Safety and Efficacy of Tag‐7 Gene‐Modified Tumor Cells‐Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer
The Oncologist, EarlyView.
Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative
The Oncologist, EarlyView.
Identifying Geriatric Oncology Competencies for Medical Oncology Trainees: A Modified Delphi Consensus Study
The Oncologist, EarlyView.
Lack of Association Between Radiographic Tumor Burden and Efficacy of Immune Checkpoint Inhibitors in Advanced Lung Cancer
The Oncologist, EarlyView.
Cancer Research Ethics and COVID‐19
The Oncologist, EarlyView.
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte‐to‐Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer
The Oncologist, EarlyView.
Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration‐Sensitive Prostate Cancer
The Oncologist, EarlyView.
Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation
The Oncologist, EarlyView.
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders
The Oncologist, EarlyView.
Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pancreatic Cancer
The Oncologist, EarlyView.
Hormone Receptor–Positive/Human Epidermal Growth Receptor 2–Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents
The Oncologist, EarlyView.
“My Research Is Their Business, but I'm Not Their Business”: Patient and Clinician Perspectives on Commercialization of Precision Oncology Data
The Oncologist, EarlyView.
Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer
The Oncologist, Volume 25, Issue 3, Page 208-e417, March 2020.
Premature Termination of a Randomized Controlled Trial on Image‐Guided Stereotactic Body Radiotherapy of Metastatic Spinal Cord Compression
The Oncologist, Volume 25, Issue 3, Page 210-e422, March 2020.
The Impact of Nonsteroidal Anti‐Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti‐PD‐1 Therapy in Advanced Melanoma
The Oncologist, Volume 25, Issue 3, Page e602-e605, March 2020.
Access to Novel Drugs for Non‐Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis
The Oncologist, Volume 25, Issue 3, Page e598-e601, March 2020.
Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?
The Oncologist, Volume 25, Issue 3, Page e555-e569, March 2020.
Table of Contents for The Oncologist. List of articles from both the latest and EarlyView issues.
Subscribe to Early View from The Oncologist feed